Omni-PAGE?預制膠(Hepes-Tris)
Omni-PAGE?Hepes-Tris Gels
本產品常溫運輸;4℃可保存18個月。切勿置于0℃以下,以免凝膠發生凍裂。
產品組分
產品特點
go
o穩定性高——采用(yong)自動化(hua)灌膠生(sheng)產技術(shu),確保(bao)了產品質量的高穩定(ding)性(xing)和重(zhong)復性(xing);
go
o晰——采用玻璃膠板,有效(xiao)減少蛋(dan)白非特異性吸附,使蛋(dan)白條帶更為尖銳,清晰(xi);
go
o電泳快速——電泳時間短,在150V電(dian)壓下(xia),電(dian)泳40~50min即可完成;
go
o操作簡便——膠(jiao)夾打開極為輕(qing)(qing)松(song),只需用刀(dao)片在膠(jiao)夾一側輕(qing)(qing)輕(qing)(qing)劃一下即(ji)可打開;
go
o通用性強——凝膠(jiao)中不含(han)SDS,可(ke)用于變性和(he)非變性電泳(需使用非變性電泳液);
go
o兼容性強——兼容市場上主流的(de)mini電泳槽,如Bio-Rad,Invitrogen,天能(neng)和君意東(dong)方等;
go
o種類多樣——提供多種濃(nong)度(du)的均一(yi)膠和梯度(du)膠。均一(yi)膠可選濃(nong)度(du):8%,10%,12%,15%。梯度(du)膠可選濃度(du):4~15%,4~20%,8~20%。
產(chan)品簡(jian)介
goodOmni-PAGE?預(yu)制膠(Hepes-Tris)是一款安(an)全、快捷、高性能的預(yu)制聚丙烯(xi)酰胺凝膠(jiao),常用于(yu)PAGE和Western Blot檢測(ce)。本預(yu)制膠含有1.5cm高(gao)度的(de)4%濃縮膠。丙烯酰胺(an)與甲叉(cha)雙丙烯酰胺(an)的(de)比例為(wei)29:1,凝膠厚度為1.5mm,加樣(yang)孔(kong)數(shu)為10孔/15孔,最大上樣量為60μL/30μL,膠板尺寸:寬×高×厚度為98×84×4.1mm;凝膠尺寸為:寬×高×厚度為81 × 74×1.5mm。
1. Mei, J., Zhou, W. J., Zhu, X. Y., Lu, H., Wu, K., Yang, H. L., ... & Wang, J. (2018). Suppression of autophagy and HCK signaling promotes PTGS2high FCGR3? NK cell differentiation triggered by ectopic endometrial stromal cells. Autophagy, 14(8), 1376-1397. (IF 16.016)
good2. Ji, L., Qian, W., Gui, L., Ji, Z., Yin, P., Lin, G. N., ... & Gao, W. Q. (2020). Blockade of β-Catenin–Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration. Cancer Research, 80(10), 2004-2016. (IF 12.701)
good3. LI, Jing, et al. Selenium Status in Diet Affects Acetaminophen-Induced Hepatotoxicity via Interruption of Redox Environment. Antioxidants & Redox Signaling, 2021, 34.17: 1355-1367.(IF 8.401)
good4. Li, J., Cheng, P., Li, S., Zhao, P., Han, B., Ren, X., ... & Lu, J. (2020). Selenium status in diet affects acetaminophen-induced hepatotoxicity via interruption of redox environment. Antioxidants and Redox Signaling, (ja). (IF 8.401)
good5. LIU, Suxian, et al. Uncovering the Mechanism of Curcuma in the Treatment of Ulcerative Colitis Based on Network Pharmacology, Molecular Docking Technology, and Experiment Verification. Evidence-Based Complementary and Alternative Medicine, 2021, 2021.(IF 2.629)